A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)
2020-07-04
عنوان الدراسة
A 24 month, multicenter, randomized, open-label safety and efficacy study of concentration-controlled everolimus with reduced calcineurin inhibitor in de novo renal transplantation - Advancing renal TRANSplant eFficacy and safety Outcomes with an eveRolimus-based regiMen (TRANSFORM)
داعم الدراسة
Novartis
دواء الدراسة
Everolimus
رقم بروتوكول الدراسة
CRAD001A2433
حالة الدراسة
Ongoing
موقع الدراسة
Prince Sultan Military Medical City (Riyadh), King Fahad Specialist Hospital (Dammam)
مرحلة الدراسة
4
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。